Skip to main content

Nextel Medical Corp.

MAJI
Exchange
OTC
Industry
Communications Services, NEC
SEC CIK
0001492448

No open-market purchases or sales by Nextel Medical Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of MAJI

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nextel Medical Corp., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Nextel Medical Corp. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Nextel Medical Corp., newest first.

No Schedule 13D or 13G filings on Nextel Medical Corp. are on file.

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Nextel Medical Corp. shares, newest first.

Form 144 notices for MAJI
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 8, 20233:28 PM ETBlue Ridge Enterprises LLC/Donald SteinbergCEO380.0K$76.0KSep 7, 2023Scottsdale Capital AdvisorsSEC